107
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Implementation of treatment recommendations for chronic hepatitis B in patients attending specialized hospital care in Denmark – a region wide study

, , , , , , , , , , , & show all
Pages 843-847 | Received 17 Dec 2019, Accepted 03 Jun 2020, Published online: 22 Jun 2020

References

  • World Health Organization, World Health Organization & Global Hepatitis Programme. Global hepatitis report, 2017; 2017.
  • Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48(2):335–352.
  • Hansen N, Hay G, Cowan S, et al. Hepatitis B prevalence in Denmark – an estimate based on nationwide registers and a national screening programme, as on 31 December 2007. Eurosurveillance. 2013;18(47):20637.
  • Andersen PH. Epinyt: Akut og kronisk hepatitis B; 2015. https://www.ssi.dk/Aktuelt/Nyhedsbreve/EPI-NYT/2016/Uge9-2016.aspx
  • Lok ASF, McMahon BJ, Brown RS, et al. Antiviral therapy for chronic hepatitis B viral infection in adults: systematic review and meta-analysis. Hepatology. 2016;63(1):284–306.
  • Weis N, Clausen MR, Christensen PB, et al. Behandling af hepatitis B virus (HBV) og hepatitis C virus (HCV) infektion En guideline 8. udgave. http://www.infmed.dk/download?UID=8a805dc666d9b569d8aed7a70f309df2cfeaf6f4. 2017
  • European Association for the Study of the Liver (EASL) EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370–398.
  • Jung CW, Tan J, Tan N, et al. Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population. J Gastroenterol Hepatol. 2010;25(2):369–375.
  • Zhang S, Ristau JT, Trinh HN, et al. Undertreatment of Asian chronic hepatitis B patients on the basis of standard guidelines: a community-based study. Dig Dis Sci. 2012;57(5):1373–1383.
  • Nguyen VG, Wan K, Trinh HN, et al. Chronic hepatitis B treatment eligibility and actual treatment rates in patients in community gastroenterology and primary care settings. J Clin Gastroenterol. 2015;49:145–149.
  • Voulgaris T, Vlachogiannakos J, Ioannidou P, et al. Adherence to follow-up and treatment recommendations in Greek and immigrant patients with chronic hepatitis B in Greece. Eur J Gastroenterol Hepatol. 2017;29:264–270.
  • Giannini EG, Marenco S, Boni S, et al. Therapeutic management of chronic hepatitis B in clinical practice: a region-wide survey. J Clin Gastroenterol. 2015;49(3):228–234.
  • Kim LH, Nguyen VG, Trinh HN, et al. Low treatment rates in patients meeting guideline criteria in diverse practice settings. Dig Dis Sci. 2014;59(9):2091–2099.
  • Hansen N, Obel N, Christensen PB, et al.; DANHEP Group. Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study. J Viral Hepatol. 2009;16(9):659–665.
  • Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24(2):289–293.
  • StataCorp. 2015. Stata statistical software: Release 14. College Station (TX): StataCorp LP.
  • Kennedy PTF, Litwin S, Dolman GE, et al. Immune tolerant chronic hepatitis B: the unrecognized risks. Viruses. 2017;9(5):96.
  • Chen C-J. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295(1):65–73.
  • Chan HLY, Chan CK, Hui AJ, et al. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA. Gastroenterology. 2014;146(5):1240–1248.
  • Jonas MM, Lok ASF, McMahon BJ, et al. Antiviral therapy in management of chronic hepatitis B viral infection in children: a systematic review and meta-analysis. Hepatol Baltim Md. 2016;63(1):307–318.
  • Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update, vol. 10. India: Springer; 2016.
  • Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599.
  • Konstantinou D, Deutsch M. The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management. Ann Gastroenterol. 2015;28(2):221–228.
  • Folmann Hempler N, Diderichsen F, Larsen FB, et al. Do immigrants from Turkey, Pakistan and Yugoslavia receive adequate medical treatment with beta-blockers and statins after acute myocardial infarction compared with Danish-born residents? A register-based follow-up study. Eur J Clin Pharmacol. 2010;66(7):735–742.
  • Frederiksen HW, Zwisler A-D, Johnsen SP, et al. Differences in initiation and discontinuation of preventive medications and use of non-pharmacological interventions after acute coronary syndrome among migrants and Danish-born. Eur Heart J. 2018;39(25):2356–2364.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.